NCT05705375

Brief Summary

The goal of this clinical trial is to learn how waterpipe (WP) size affects smoking behavior, toxicant exposure, and subjective experiences in young adult WP smokers (ages 21-39). The main questions it aims to answer are:

  • Does WP size change puffing behavior?
  • Does WP size change exposure to nicotine and carbon monoxide?
  • Does WP size change perceptions of harm, satisfaction, craving, or withdrawal? Participants will smoke small, medium, and large WPs in separate sessions. Researchers will measure puffing behavior, saliva nicotine, exhaled carbon monoxide, and survey responses before and after each session.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 22, 2022

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

December 22, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 30, 2023

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2024

Completed
1.6 years until next milestone

Results Posted

Study results publicly available

November 5, 2025

Completed
Last Updated

November 5, 2025

Status Verified

September 1, 2025

Enrollment Period

1.9 years

First QC Date

December 22, 2022

Results QC Date

June 27, 2025

Last Update Submit

October 15, 2025

Conditions

Outcome Measures

Primary Outcomes (12)

  • Waterpipe Evaluation Scale

    An 11-item questionnaire assessing participants' subjective experience of smoking waterpipe (WP) tobacco. Each item is scored on a 7-point Likert scale (1 = "not at all" to 7 = "extremely"). For analysis, item scores were averaged across the 11 items to produce a mean WES score for each WP size, with higher scores indicating a more satisfactory smoking experience. The scale captures aspects such as satisfaction, taste, cravings, and sensory enjoyment in the throat and chest.

    Immediately after the exposure (smoking)

  • Duke Sensory Questionnaire

    A 9-item questionnaire assessing participants' sensory experience of smoking waterpipe (WP) tobacco. Each item is scored on a 7-point Likert scale (1 = "not at all" to 7 = "extremely"). Item scores were averaged across the 9 items to produce a mean DSQ score for each WP size, with higher scores indicating a more positive sensory experience (e.g., satisfaction, perceived nicotine strength, and puff intensity).

    Immediately after the exposure (smoking)

  • Harm Perception Questionnaire

    This is a 3-item scale assessing participants' perception of the harmfulness of waterpipe (WP) tobacco smoking. Each item is scored on a 7-point Likert scale ranging from 1 = "a lot less harmful" to 7 = "a lot more harmful." Item scores were averaged across the 3 items to produce a mean harm perception score for each WP size, with higher scores indicating greater perceived harm.

    Immediately after the exposure (smoking)

  • Saliva Nicotine

    How participants' nicotine concentrations change based on the different smoked waterpipe sizes

    Immediately after the exposure (smoking)

  • Puff Topography: Smoking Time

    The total time spent smoking during a single WP session, measured in minutes. Longer times indicate greater duration of smoking across WP sizes.

    During the exposure (smoking), up to 45 mins

  • Puff Topography: Cumulative Puff Time

    The total time spent actively inhaling smoke across all puffs in a WP session, measured in minutes using a puff topography device. Higher values indicate more total inhalation time.

    During the exposure (smoking), up to 45 mins

  • Puff Topography: Puff Duration

    The average length of each puff in seconds, measured using a puff topography device in the WP hose. Longer puff duration indicates deeper inhalation per puff.

    During the exposure (smoking), up to 45 mins

  • Puff Topography: Average Flow Rate

    The average rate of smoke inhaled per second during puffing, measured in liters per minute with a puff topography device. Higher flow rates indicate faster inhalation.

    During the exposure (smoking), up to 45 mins

  • Puff Topography: Number of Puffs

    The total number of puffs taken during a WP session, measured using a puff topography device. Higher counts indicate more frequent puffing.

    During the exposure (smoking), up to 45 mins

  • Puff Topography: Total Smoke Volume Inhaled

    Total smoke inhaled during a single WP session, measured in liters using a puff topography device in the WP hose. Higher values indicate greater smoke intake across WP sizes.

    During the exposure (smoking), up to 45 mins

  • Puff Topography: Puff Volume Average

    Mean volume of each puff during a WP session, measured in liters using a puff topography device in the WP hose. Higher values indicate larger puff sizes across WP sizes.

    During the exposure (smoking), up to 45 mins

  • Puff Topography: Maximum Puff Volume

    The largest single puff volume inhaled during a WP session, measured in liters using a puff topography device. Higher values indicate the strongest inhalation effort across puffs.

    During the exposure (smoking), up to 45 mins

Study Arms (1)

waterpipe regular smokers

EXPERIMENTAL

waterpipe regular smokers will be invited for 3 lab visits where they are allocated (random order) to smoke 3 waterpipe different sizes.

Other: Waterpipe size

Interventions

Participants will have 3 lab visits where they are allocated (random order) to smoke a small waterpipe in one visit, smoke a medium waterpipe in a second visit and smoke a large waterpipe in a third visit.

waterpipe regular smokers

Eligibility Criteria

Age21 Years - 39 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • regular waterpipe smokers (smoking at least once a week for the past 6 months)
  • generally healthy and
  • able to provide written informed consent; and willing to attend the 3 lab sessions

You may not qualify if:

  • history of chronic diseases such as diabetes, high blood cholesterol, hepatic disease
  • respiratory chronic diseases
  • cardiovascular diseases including low or high blood pressure (BP)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Texas at Arlington

Arlington, Texas, 76019, United States

Location

Results Point of Contact

Title
Ziyad Ben Taleb
Organization
University of Texas at Arlington

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 22, 2022

First Posted

January 30, 2023

Study Start

April 22, 2022

Primary Completion

February 28, 2024

Study Completion

March 30, 2024

Last Updated

November 5, 2025

Results First Posted

November 5, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations